Figures and Tables
From the following article:
The IL-33/ST2 pathway: therapeutic target and novel biomarker
Rahul Kakkar & Richard T. Lee
Nature Reviews Drug Discovery 7, 827-840 (October 2008)
doi:10.1038/nrd2660
Figure 1
A model for IL-33/ST2 signalling.
Figure 2
IL-33 in the type 2 immune response.
Figure 3
IL-33/ST2 signalling is a novel cardioprotective fibroblast–cardiomyocyte paracrine system.
Figure 4
IL-33/ST2 reduces atheroma formation.
Figure 5
Strategies and consequences of IL-33/ST2 modulation.
